NCT07093723View on ClinicalTrials.gov

Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
S100BNeutrophils/Lymphocytes RatioPredictionBrain Injury
Interventions
DIAGNOSTIC_TEST

S100B Protein

Serum level of S100B Protein was measured on the first and third days of seizure activity by ELISA.

DIAGNOSTIC_TEST

Neutrophils to Lymphocytes ratio

Neutrophils to Lymphocytes ratio was measured on the first and third day of seizure activity obtained by complete blood count.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07093723 - Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury | Biotech Hunter | Biotech Hunter